$YETI Holdings Inc.(YETI)$ kkzenmy

$Xtant Medical Holdings Inc(XTNT)$?

$FAT Brands Inc(FATBW)$FAT Brands Inc. (Nasdaq: FAT, FATBP, FATBW), today announced the closing of its previously announced underwritten public offering (the "Offering") of 360,000 shares of 8.25% Series B Cumulative Preferred Stock ("Series B Preferred Stock") and 1,899,000 warrant (the "Warrants") to each purchase one share of Common Stock at an exercise price of $5.00 per share, including 99,000 Warrants as a result of a partial exercise of the over-allotment option granted to the underwriter.

$OncoCyte Corporation(OCX)$IRVINE, Calif., June 15, 2020 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced its transition to a revenue generating, commercial stage company. Oncocyte has received reimbursement for DetermaRx™ from multiple commercial payers. In addition, Oncocyte has submitted its first claims for DetermaRx under the Centers for Medicare & Medicaid Services (CMS) reimbursement program.

$NeuroBo Pharmaceuticals, Inc.(NRBO)$BOSTON, April 14, 2020 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale in a registered direct offering of 750,000 shares of the Company's common stock, at a purchase price of $10.00 per share. The closing of the offering is expected to occur on or about April 16, 2020, subject to the satisfaction of customary closing conditions.

$8i Enterprises Acquisition Corp(JFKKR)$NEW YORK, April 02, 2020 (GLOBE NEWSWIRE) -- 8i Enterprises Acquisition Corp. (NASDAQ: JFKKU, JFK, JFKKW, JFKKR) (“JFK” or the “Company”), a special purpose acquisition company, today announced that Diginex, a digital asset financial services and advisory company with which JFK entered into a definitive share exchange agreement dated July 9, 2019, has hired Mr. Chi-Won Yoon as Chairman of Asia. Based in Hong Kong, Mr. Yoon will work closely with Diginex business heads to bring its digital asset financial services and blockchain solutions to partners and investors throughout Asia.